A second pivotal trial of piclidenoson for the treatment of rheumatoid arthritis
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Piclidenoson (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms ACROBAT
- 07 Aug 2017 According to a Can-Fite BioPharma media release, this trial is expected to initiate in 2017.
- 07 Aug 2017 According to a Can-Fite BioPharma media release, based on the favorable safety data from cardiodynamic trial CTP#700287672 company is cleared to initiate this study.
- 07 Nov 2016 According to a Can-Fite BioPharma media release, protocol has recently been agreed with EMA.